Investigation of the Effect of Intranasal Oxytocin on Relapse Risk in Cocaine-dependent Patients
Active, no longer recruiting
Phase of Trial: Phase II/III
Latest Information Update: 04 Nov 2016
At a glance
- Drugs Oxytocin (Primary)
- Indications Cocaine abuse
- Focus Therapeutic Use
- 11 Oct 2016 Planned End Date changed from 1 Oct 2016 to 1 Dec 2016.
- 11 Oct 2016 Planned primary completion date changed from 1 May 2016 to 1 Dec 2017.
- 11 Oct 2016 Status changed from recruiting to active, no longer recruiting.